Apimeds Pharmaceuticals U... (APUS)
NYSE: APUS
· Real-Time Price · USD
1.78
0.06 (3.49%)
At close: Oct 03, 2025, 3:59 PM
1.79
0.56%
After-hours: Oct 03, 2025, 04:26 PM EDT
Apimeds Pharmaceuticals US Inc Revenue
Apimeds Pharmaceuticals US Inc reported an annual revenue of $0, reflecting a 0% growth. For the quarter ending June 30, 2025, Apimeds Pharmaceuticals US Inc generated $0 in revenue.
Revenue (ttm)
0
Revenue Growth
n/a
Price / Sales Ratio
0
Revenue / Employee
0
Employees
2
Market Cap
22.37M
Revenue Chart
History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 0 | n/a |
| Dec 31, 2023 | 0 | n/a |
| Dec 31, 2022 | 0 | n/a |
| Dec 31, 2021 | 0 | n/a |